News
13hon MSN
A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric symptoms and potentially slowing cognitive decline in Parkinson's disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results